Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
First Perjeta Biosimilar Is Approved In The US For Henlius And Organon
Poherdy Rival To Pertuzumab Also Wins Interchangeability Designation
Nov 14 2025
•
By
Dave Wallace
Poherdy stands alone as the only pertuzumab biosimilar so far approved by the FDA
(Shutterstock)
More from Biosimilars
More from Products